Advertisement

ASCO Lung Cancer 2022Latest

Once-Daily Radiotherapy Preferred by Patients With Limited Stage Small Cell Lung Cancer

Jul 14, 2022

High-dose, once-daily thoracic radiotherapy (TRT) and standard twice daily TRT were well tolerated by patients with LS-SCLC, although many preferred the convenience of the once-a-day regimen. &....

More Meeting Coverage

ASCO Leukemia 2022Latest

AAN 2022Latest

ACTRIMS 2022Latest

SGO 2022Latest

ASCO GU 2022Latest

ASH 2021Latest

ASH 2021: A Focus on Leukemia & Lymphoma

Jan 12, 2022

Focus on Lymphoma Leukemia....

CMSC 2021Latest

CMSC: Natalizumab for MS During the Covid-19 Pandemic

Jan 05, 2022

Overall outcomes good after Covid infection, vaccine for most patients At the recent Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, several researchers shed light on how patients wit....

ASOPRS 2021Latest

Take Our ASOPRS Quiz!

Jan 11, 2022

The ASOPRS 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. The ASOPRS 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly.....

ASN 2021Latest

ASN 2021: A Focus on Chronic Gout eBook

Dec 15, 2021

Focus on ASN Chronic Gout.indd....

ASCO 2021 LymphomaLatest

ACR 2021Latest

ACR 2021: A Focus on Chronic Gout eBook

Dec 18, 2021

Focus on ACR Chronic Gout.indd....

ECTRIMS 2021Latest

ESC 2021 Heart FailureLatest

ESC: Finerenone Demonstrates CVD Benefit in FIGARO-DKD

Dec 30, 2021

Benefit driven by 29% relative reduction in heart failure hospitalization SGLT2 inhibitors were not the only treatments in 2021 showing cardiac benefit for patients with chronic kidney disease and ty....

ASCO 2021 LeukemiaLatest

Precision Medicine: It’s All About Biomarker Testing

Jan 03, 2022

Guidelines recommend biomarker testing, but is it done? Next-generation sequencing (NGS) may help increase biomarker testing rates in patients with metastatic NSCLC, but are clinicians taking advanta....